These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22613639)

  • 1. Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels.
    Li G; Xu YL; Ling F; Liu AJ; Wang D; Wang Q; Liu YL
    Chin Med J (Engl); 2012 Apr; 125(8):1381-8. PubMed ID: 22613639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
    Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L
    Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
    J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
    Yan D; Li G; Zhang Y; Liu Y
    Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
    [No Abstract]   [Full Text] [Related]  

  • 5. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.
    Ferreira AJ; Shenoy V; Yamazato Y; Sriramula S; Francis J; Yuan L; Castellano RK; Ostrov DA; Oh SP; Katovich MJ; Raizada MK
    Am J Respir Crit Care Med; 2009 Jun; 179(11):1048-54. PubMed ID: 19246717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changes of serum angiotensin-converting enzyme 2 in patients with pulmonary arterial hypertension due to congenital heart disease.
    Dai HL; Guo Y; Guang XF; Xiao ZC; Zhang M; Yin XL
    Cardiology; 2013; 124(4):208-12. PubMed ID: 23548773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
    Haga S; Tsuchiya H; Hirai T; Hamano T; Mimori A; Ishizaka Y
    Exp Lung Res; 2015 Feb; 41(1):21-31. PubMed ID: 25275723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels.
    Shen L; Shen J; Pu J; He B
    Cell Biochem Biophys; 2011 Sep; 61(1):23-31. PubMed ID: 21327581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Ito T; Okada T; Miyashita H; Nomoto T; Nonaka-Sarukawa M; Uchibori R; Maeda Y; Urabe M; Mizukami H; Kume A; Takahashi M; Ikeda U; Shimada K; Ozawa K
    Circ Res; 2007 Sep; 101(7):734-41. PubMed ID: 17673672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism.
    Luan Y; Zhang X; Kong F; Cheng GH; Qi TG; Zhang ZH
    Int Immunopharmacol; 2012 Dec; 14(4):432-7. PubMed ID: 22922316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichloroacetate prevents but not reverses the formation of neointimal lesions in a rat model of severe pulmonary arterial hypertension.
    Li B; Yan J; Shen Y; Liu Y; Ma Z
    Mol Med Rep; 2014 Oct; 10(4):2144-52. PubMed ID: 25110234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
    Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
    Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
    Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN
    Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer.
    Yamazato Y; Ferreira AJ; Hong KH; Sriramula S; Francis J; Yamazato M; Yuan L; Bradford CN; Shenoy V; Oh SP; Katovich MJ; Raizada MK
    Hypertension; 2009 Aug; 54(2):365-71. PubMed ID: 19564552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL; Guan RJ; Xu QH; Wu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.